A COVID-19 vaccine breakthrough would have a material impact on global stock markets, so will we see a vaccine in 2021? One of the world's leading experts in vaccine development believes it's more than likely. 

Dr Michael Farzan, Professor and Chair of the Department of Immunology and Microbiology at Scripps Research Institute discusses the pathway to COVID-19 vaccination with Antipodes Healthcare Sector Head, Dr Nick Cameron.